Global Stem Cells Group and Marina Medical Announce …

Global Stem Cells Group and Marina Medical, Inc. announce plans to conduct joint stem cell training courses worldwide. GSCG subsidiary Adimarket will distribute stem cell products to Latin America in conjunction with the joint training program.

MIAMI (PRWEB) June 04, 2015

MIAMI, June 4, 2015Global Stem Cells Group and Marina Medical, Inc. have announced plans to conduct joint stem cell training courses for physicians and qualified medical professionals worldwide. Sunrise, Florida-based Marina Medical is an established leader in design, manufacture and distribution of medical devices for OBGYN, plastic and aesthetic surgery, regenerative medicine and urogynecology.

Marina Medicals recently launched Koume Cannalus division manufactures instruments for regenerative medicine procedures. Teaming with GSCG for the stem cell training courses will help to further stem cell education among those medical professionals who use Marina Medical instruments.

Global Stem Cells Group subsidiary Adimarket will provide regenerative medicine equipment and supplies for the joint training session held in Latin America.

The Adipose and Bone Marrow Stem Cell Training Course was developed for physicians and high-level practitioners to learn the process of isolating and re-integrating adipose- and bone marrow-derived stem cells through an intensive, hands-on training session. The objective is to arm participating physicians with clinical protocols and state-of-the-art techniques so that they can bring regenerative medicine therapies to their patients in-office.

Global Stem Cells Groups Stem Cell Training, Inc. courses have been extended to approximately 35 countries, allowing a global community of physicians to learn how to apply these new stem cell technologies. For more information, visit the Global Stem Cells Group website, email bnovas(at)stemcellsgroup(dot)com, or call 305-224-1858.

About Global Stem Cells Group:

Global Stem Cells Group, Inc. is the parent company of six wholly owned operating companies dedicated entirely to stem cell research, training, products and solutions. Founded in 2012, the company combines dedicated researchers, physician and patient educators and solution providers with the shared goal of meeting the growing worldwide need for leading edge stem cell treatments and solutions.

With a singular focus on this exciting new area of medical research, Global Stem Cells Group and its subsidiaries are uniquely positioned to become global leaders in cellular medicine. Global Stem Cells Groups corporate mission is to make the promise of stem cell medicine a reality for patients around the world. Each of GSCGs six operating companies focus on a separate research-based mission; the result is a global network of state-of-the-art stem cell treatments and facilities.

Follow this link:
Global Stem Cells Group and Marina Medical Announce ...